Manuscript Type: Original Article
Title: Phase 1 Study of Cabozantinib in Combination with
Topotecan- Cyclophosphamide for Patients with Relapsed Ewing Sarcoma or
Osteosarcoma
Authors: Kevin Campbell, MD1*, Andrew
Posner1, Nan Chen1, Kerri Cavanaugh,
RN1; Ketki Bhushan1, Katherine A.
Janeway, MD1, David S. Shulman, MD1,
Suzanne George, MD2, Kelly Klega, Brian Crompton, MD,
Wendy B. London, PhD1, Steven G. DuBois, MD
MS1
Author Affiliations: 1Dana-Farber / Boston
Children’s Cancer and Blood Disorders Center and Harvard Medical School,
Boston, MA; 2Dana-Farber Cancer Institute and Harvard
Medical School, Boston, MA.
*Current Affiliation: Children’s Mercy Hospital, Department of
Hematology, Oncology, Kansas City, MO